Importantly, systematic analysis of differentially expressed genes between AD patients and controls indicated that Ndufa1 could be used as a predictive candidate biomarker for mild cognitive impairment (MCI) and AD [31]. This evidence concerns the gene NDUFA1 and Alzheimer disease.